Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
The T-win® technology: immune-modulating vaccines
Mads Hald Andersen
*
*
Corresponding author for this work
11
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The T-win® technology: immune-modulating vaccines'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Immune Regulation
100%
Indoleamine 2,3-dioxygenase 1 (IDO1)
50%
Programmed Death-ligand 1 (PD-L1)
50%
Tumor Microenvironment
50%
Regulatory Immune Cells
50%
Inhibitory Pathways
25%
Arginase
25%
Vaccination
25%
Therapeutic Vaccination
25%
Long Peptides
25%
Effector Cells
25%
Tumor Antigen
25%
Antigen Expression
25%
Regulatory Environment
25%
Stable Cell Line
25%
CD-8
25%
Clinical Trials
25%
Dioxygenase
25%
Inflammatory Cells
25%
Peptide Epitopes
25%
T Cells
25%
Human Leukocyte Antigen
25%
Regulatory Cells
25%
Malignant Cells
25%
Medicine and Dentistry
Immunity
100%
Indoleamine 2,3 Dioxygenase
50%
Immunocompetent Cell
50%
Tumor Microenvironment
50%
Programmed Death 1 Ligand 1
50%
Human Leukocyte Antigen
25%
Tumor Antigen
25%
Neoplasm
25%
Epitope
25%
Arginase
25%
Effector Cell
25%
Dioxygenase
25%
Tryptophan
25%
T Cell
25%
Inflammatory Cell
25%
T-Cell Response
25%
Regulatory T Cell
25%
Clinical Trial
25%
Antigen Expression
25%
CD8 Antigen
25%
Immunology and Microbiology
Immunity
100%
Regulatory T Cell
100%
Immunocompetent Cell
40%
Programmed Death 1 Ligand 1
40%
Indoleamine 2,3-dioxygenase
40%
T Cell
40%
Dioxygenase
20%
Antigen Expression
20%
Inflammatory Cell
20%
Peptides
20%
Tumor Antigen
20%
CD4
20%
Effector Cell
20%
Tryptophan
20%
Epitope
20%
Human Leukocyte Antigen
20%
CD8
20%